References
- Dixon D. O., Neilan B., Jones S. E., et al. Effect of age and therapeutic outcome in advanced diffuse histiwytic lymphoma: The Southwest Oncology Group experience. J Clin Oncol 1986; 4: 295–305
- Zagonel V., Tirelli U., Carbone A. Treatment of non-Hodgkin's lymphoma in the elderly. J Clin Oncol 1986; 4(12)1866–1867
- O'Connell M. J., Earle J. D. Initial chemotherapy doses for elderly patients with malignant lymphoma. J Clin Oncol 1986; 4(9)1418
- Peterson B. A., Pajak T. I., Cooper M. R., et al. The effects of age on therapeutic response and survival in advanced Hodgkin's disease. Cancer Treat Rep 1982; 66: 889–898
- Burgers J. MV, Ishak Sharouni S., Hart G. M., et al. Correlation between age and prognosis in Hodgkin's disease (HD). III International Conference on Malignant Lymphoma, abs T66 p129, Lugano, June, 10–131987
- Eghbali H., Hoemi-Simon G., Deascarel M. I., et al. Hodgkin's disease in the elderly: A series of 30 patients aged older than 70 years. Cancer 1984; 53: 2191–2193
- Tirelli U. on behalf of the EORTC Lymphoma hperative Group: Treatment-related toxicity in elderly patients with malignant lymphoma. J Clin Oncol 1987; 5(4)680–681